The conversation discusses whether RU58841, if FDA approved and safe, would be recommended over finasteride for hairloss. Specific treatments mentioned include RU58841, finasteride, and minoxidil.
The conversation is about skepticism regarding new hairlosstreatments until they are FDA approved. People have been joking about treatments being 5-7 years away for decades.
The user is exploring KX-826 as a potential hairlosstreatment due to intolerance to FDA-approved drugs like Minoxidil and finasteride. They seek fundamental help and information about KX-826.
A YouTuber named Kevin, also known as Rider_Of_Roach, who deleted his YouTube channel due to personal attacks and controversy surrounding his views on hairlosstreatments. He advocated for FDA-approvedtreatments like finasteride and minoxidil but faced backlash from those who disagreed with him. The conversation also discusses his past trolling behavior and a lawsuit he filed against a website that published false information about him. Despite some disagreements, many viewers appreciated his research-based content and hope to see him return in the future.
New potential hairlosstreatment uses molecules from hairy moles to stimulate follicle growth. Topical solution requires less frequent application, like Botox injections a few times per year.
OP is pausing hairlosstreatments to focus on mental health due to anxiety and side effects from RU58841. They plan to try topical finasteride and minoxidil after recovering from pneumonia.
The conversation is about the approval of Clascoterone (Winlevi) in Canada for hairlosstreatment. One user expressed skepticism about its effectiveness due to low concentration.
A user is concerned about using Alpicort, which contains Prednisolone and Salicylic Acid, for male pattern baldness. They are unsure if it will help or worsen their condition and are seeking advice.
The conversation discusses the progress of Clascoterone (Breezula) for hairlosstreatment, noting that COVID-19 delayed female trials by three months but Phase III trials for males are proceeding with a Special Protocol Assessment filed with the FDA. Users express hope for Breezula as an alternative to existing treatments like finasteride and minoxidil, despite concerns about its potential high cost.
The conversation discusses dissatisfaction with current hairlosstreatments that mainly focus on DHT blockers like finasteride and dutasteride. Alternative treatments mentioned include RU58841, pyrilutamide, minoxidil, rosemary oil, and future possibilities like hair cloning.
Rating treatments for hairloss, with the help of GPT-4, according to efficacy, evidence and tolerability; a combination of chemicals from research papers, custom compounds, and some suggestions from other users were included.
The post discusses frustration over the limited and not always effective treatments for hairloss, mainly Minoxidil and Finasteride. The conversation includes mentions of potential new treatments like GT20029, HMI-115, CosmeRNA, KX-826, and microneedling, but also highlights the challenges of funding and prioritizing research in this area.
The conversation discusses the availability of Breezula, a drug for hairloss, now being sold as an acne treatment, and whether it can be applied to the scalp. Users express skepticism about new hairlosstreatments and suggest waiting for FDA approval.
CRISPR shows promise for treating hairloss by targeting specific genes. Current treatments include Minoxidil and finasteride, but CRISPR could offer a more precise solution, though it is still expensive and in early stages.
The conversation discusses why CB-03-01, a potential hairlosstreatment, isn't widely discussed despite evidence of its effectiveness and safety. Some users mention other treatments like melatonin, procianidin b2, and RU58841, debating their effectiveness and safety.
A user shared their experience with hairlosstreatments, including RU58841, ketoconazole shampoo, caffeine shampoo, and topical finasteride. They found RU58841 effective for diffuse thinning but experienced severe hairloss after stopping it; topical finasteride worked well for a receding hairline but caused side effects. They also use a charcoal shampoo and practice scalp massages.
GT20029, a new hairlosstreatment, shows promising results but only a slight improvement over placebo. People are cautiously optimistic, discussing its potential and combining it with existing treatments like Minoxidil and Finasteride.
Hairlosstreatments, specifically the use of Alfatradiol as an over-the-counter topical 5AR inhibitor that has been shown to be effective in stopping hairloss without side effects. Other treatments discussed include Minoxidil, finasteride and RU58841.
A 29-year-old male experiencing hairloss due to TRT is using minoxidil and dermarolling but is hesitant to use finasteride or dutasteride due to potential side effects. He is considering low level laser therapy (LLLT), PRP, ketoconazole shampoo, and oral minoxidil as additional treatments. A reply suggests that without a DHT blocker like finasteride or dutasteride, other treatments may not be effective long-term.
The conversation discusses hairlosstreatments beyond the commonly known three, focusing on separating effective treatments from myths. Dutasteride and low-dose oral Minoxidil are mentioned as having clinical evidence for increasing hair counts, but with potential side effects.
The user regrets not continuing hairlosstreatment with finasteride earlier and plans to restart it along with minoxidil. Another user suggests trying dutasteride and oral minoxidil as a more effective treatment.
The conversation discusses a user's experience with hairlosstreatments, specifically using finasteride for almost 5 months and minoxidil for 8 months. The user is considering switching to oral minoxidil and possibly dutasteride if not satisfied with the results, despite others noting progress and advising patience.
The conversation discusses the lack of significant advancements in hairlosstreatments beyond finasteride and minoxidil, questioning if hair restoration technology has reached a dead end. Hair transplant technology has improved, but new medications face challenges with market entry, cost, accessibility, and long-term effectiveness.
A clinical trial for Verteporfin as a hairlosstreatment, and the potential for greater progress in treatments for hairloss in the future. Common treatments such as Minoxidil, Finasteride and RU58841 were discussed.
The conversation discusses the potential of new hairlosstreatments, with a focus on pyrilutamide, gt20029, and topical alfatradiol, and the possibility of improving their effectiveness through methods like increased concentration and microneedling. Dutasteride is also mentioned as a stronger option.
The efficacy of various hairlosstreatments, including Finasteride and Dutasteride, with personal anecdotal evidence about potential side effects. It also includes advice to get a male hormone blood panel done before starting treatment, and lifestyle changes to minimize side effects.
Hairlosstreatments, specifically the use of oral minoxidil in combination with micro-needling. Oral minoxidil has been found to improve hair density in 90% of patients with a low side effect profile, but using 5mg per day can result in higher side effects including hypertrichosis and edema. Other treatments mentioned include finasteride and RU58841.
Hairlosstreatments discussed include Propecia, Rogaine, Nizoral shampoo, and dermarolling. Users shared experiences and results, with some noticing improvements in hair growth and maintenance.
User hoodoomoovoo discusses their interest in stem cell research and its potential for hairlosstreatment. They share links to studies and mention ongoing trials, expressing optimism for a future solution to hairloss.